packageBretylium

Bretylium

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Bretylium is a class III antiarrhythmic agent used to treat ventricular fibrillation and heart conduction disease. It is an approved drug, though it is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q420026 and the WHO ATC classification; not checked by a person.

name:Bretylium
ATC codes:C01BD02
DrugBank:DB01158
PubChem CID:2431
Wikidata:Q420026
formula:C11H17BrN+
molar mass:243.168 g/mol (PubChem CID 2431)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown